KLK3 and ocular melanoma: , more percentage of white race (89.3% vs. 72.4%), more got married (68.6% vs. 51.7%), earlier percentage of diagnosis year (2010–2014 45.3% vs. 39.2%), lower prostate-specific antigen (PSA) (98.0 ng/ml or greater: 0.5% vs. 80.4%), more percentage of localized stage (90.4% vs. 4.8%), more percentage of lymph node dissection (4 or more regional lymph nodes: 76.6% vs. 0.1%), less percentage of systemic therapy (2.3% vs. 10.6%), lower rates of CSM (4.6% vs. 49.8%) and OM (37.5% vs. 64.0%), and had longer survival time (30.00 mo.